Circulating miRNA profile in HCV infected serum: Novel insight into pathogenesis

Scientific Reports

Volumn 3, Issue , 2013, Pages

  Shwetha, Shivaprasad ^a   Gouthamchandra, K ^a   Chandra, Madhavi ^b   Ravishankar, B ^c   Khaja, M N ^b   Das, Saumitra ^a  

^a INDIAN INSTITUTE OF SCIENCE   (India)

^b Bioviz Technologies Private Limited   (India)

^c Yashoda Hospital   (India)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA;

ARTICLE; BLOOD; GENETICS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; ISOLATION AND PURIFICATION; PATHOGENICITY; SIGNAL TRANSDUCTION; VIROLOGY;

HEPACIVIRUS; HEPATITIS C; HUMANS; MICRORNAS; SIGNAL TRANSDUCTION;

EID: 84876564133     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep01555     Document Type: Article

References (31)

1. Lee, M. H. et al. Community and personal risk factors for hepatitis C virus infection: a survey of 23,820 residents in Taiwan in 1991-2. Gut 60, 688-694 (2011).
2. Kuo, G. et al. An assay for circulating antibodies to a major etiologic virus of human non-A., non-B hepatitis. Science 244, 362-364 (1989). (Pubitemid 19117878)
3. McGivern, D. R. & Lemon, S. M. Virus-specific mechanisms of carcinogenesis in hepatitis C virus associated liver cancer. Oncogene 30, 1969-1983 (2011).
4. Poynard, T. et al. A comparison of fibrosis progression in chronic liver diseases. J Hepatol 38, 257-265 (2003). (Pubitemid 36286537)
5. Jopling, C. L., Yi, M., Lancaster, A. M., Lemon, S. M. & Sarnow, P.Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA. Science 309, 1577-1581 (2005). (Pubitemid 41266486)
6. Lanford, R. E. et al. Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection. Science 327, 198-201 (2010).
7. Murakami, Y.,Aly, H. H., Tajima, A., Inoue, I.&Shimotohno, K. Regulation of the hepatitis C virus genome replication by miR-199a. J Hepatol 50, 453-460 (2009).
8. Pedersen, I. M. et al. Interferon modulation of cellular microRNAs as an antiviral mechanism. Nature 449, 919-922 (2007). (Pubitemid 47598616)
9. Zhang, Y. et al. Hepatitis C Virus-induced upregulation of miR-155 promotes hepatocarcinogenesis by activating Wnt signaling. Hepatology (2012).
10. Lee, M. H. et al. Hepatitis C virus infection and increased risk of cerebrovascular disease. Stroke; a journal of cerebral circulation 41, 2894-2900 (2010).
11. Wang, K. et al. Circulating microRNAs, potential biomarkers for drug-induced liver injury. Proc Natl Acad Sci USA 106, 4402-4407 (2009).
12. Pegtel, D. M. et al. Functional delivery of viral miRNAs via exosomes. Proc Natl Acad Sci USA 107, 6328-6333 (2010).
13. Etheridge, A., Lee, I., Hood, L., Galas, D. & Wang, K. Extracellular microRNA: a new source of biomarkers. Mutat Res 717, 85-90 (2011).
14. Xu, J. et al. Circulating microRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis. Molecular carcinogenesis 50, 136-142 (2011).
15. Bihrer, V. et al. Serum miR-122 as a biomarker of necroinflammation in patients with chronic hepatitis C virus infection. Am J Gastroenterol 106, 1663-1669 (2011).
16. Bihrer, V. et al. Serum microRNA-21 as marker for necroinflammation in hepatitis C patients with and without hepatocellular carcinoma. PLoS One 6, e26971 (2011).
17. Cermelli, S., Ruggieri, A., Marrero, J. A., Ioannou, G. N. & Beretta, L. Circulating microRNAs in patients with chronic hepatitis C and non-alcoholic fatty liver disease. PLoS One 6, e23937 (2011).
18. Shrivastava, S. et al. Upregulation of circulating miR-20a is correlated with hepatitis C virus mediated liver disease progression. Hepatology (2013).
19. Li, L. M. et al. Serum microRNA profiles serve as novel biomarkers for HBV infection and diagnosis of HBV-positive hepatocarcinoma. Cancer Res 70, 9798-9807 (2010).
20. Varnholt, H. et al. MicroRNA gene expression profile of hepatitis C virusassociated hepatocellular carcinoma. Hepatology 47, 1223-1232 (2008). (Pubitemid 351547908)
21. Ura, S. et al. Differential microRNA expression between hepatitis B and hepatitis C leading disease progression to hepatocellular carcinoma. Hepatology 49, 1098-1112 (2009).
22. Wang, L. G. & Gu, J. Serum microRNA-29a is a promising novel marker for early detection of colorectal liver metastasis. Cancer Epidemiol 36, e61-67 (2012).
23. Arzumanyan, A., Reis, H. M. & Feitelson,M. A. Pathogenic mechanisms in HBVand HCV-associated hepatocellular carcinoma. Nat Rev Cancer 13, 123-135 (2012).
24. Ukai, T., Sato, M., Akutsu, H., Umezawa, A. & Mochida, J. MicroRNA-199a-3p, microRNA-193b, and microRNA-320c are correlated to aging and regulate human cartilage metabolism. J Orthop Res 30, 1915-1922 (2012).
25. Qiao, Y. et al. MiR-483-5p controls angiogenesis in vitro and targets serum response factor. FEBS Lett 585, 3095-3100 (2011).
26. Wang, L. et al.MiR-483-5p suppresses the proliferation of glioma cells via directly targeting ERK1. FEBS Lett 586, 1312-1317 (2012).
27. Macdonald, A. et al. The hepatitis C virus non-structural NS5A protein inhibits activating protein-1 function by perturbing ras-ERK pathway signaling. J Biol Chem 278, 17775-17784 (2003).
28. Wakita, T. et al. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med 11, 791-796 (2005). (Pubitemid 41021213)
29. Kanehisa, M., Goto, S., Sato, Y., Furumichi, M. & Tanabe, M. KEGG for integration and interpretation of large-scale molecular data sets. Nucleic Acids Res 40, D109-114 (2012).
30. Szklarczyk, D. et al. The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored. Nucleic Acids Res 39, D561-568 (2011).
31. Shannon, P. et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 13, 2498-2504 (2003). (Pubitemid 37428274)